Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Infections, Respiratory Syncytial Virus”

443 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 443 results

Early research (Phase 1)Study completedNCT03213405
What this trial is testing

Assess Safety, Tolerability and Immunogenicity of the Live Attenuated hRSV Vaccine rBCG-N-hRSV

Who this might be right for
Respiratory Syncytial Virus Infections
Pontificia Universidad Catolica de Chile 24
Large-scale testing (Phase 3)Study completedNCT05110261
What this trial is testing

Evaluate the Safety and Efficacy of Nirsevimab in Healthy Preterm and Term Infants in China

Who this might be right for
Lower Respiratory Tract Infection
AstraZeneca 800
Early research (Phase 1)Study completedNCT05118386
What this trial is testing

Safety, Tolerability, and Pharmacokinetics of RSV Monoclonal Antibody RSM01 in Healthy Adults

Who this might be right for
RSV Infection
Gates Medical Research Institute 56
Testing effectiveness (Phase 2)Study completedNCT03334695
What this trial is testing

An Exploratory Study to Evaluate the Prophylactic Efficacy of a Single Immunization of Ad26.RSV.preF Against Respiratory Syncytial Virus Infection in a Virus Challenge Model in Healthy 18 to 50 Year-old Adults

Who this might be right for
Healthy
Janssen Vaccines & Prevention B.V. 64
Large-scale testing (Phase 3)Study completedNCT06374394
What this trial is testing

A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 841
Not applicableStudy completedNCT06336577
What this trial is testing

Infectious and Non-infectious Lower Respiratory Diseases in Children With Down Syndrome Followed in Pediatric Pulmonology Consultations in Ile-de-France

Who this might be right for
Down Syndrome
Centre Hospitalier Sud Francilien 108
Large-scale testing (Phase 3)Study completedNCT06325657
What this trial is testing

Learn About the Vaccine RSVpreF In Pregnant Participants With HIV and Their Infants

Who this might be right for
Respiratory Syncytial Virus
Pfizer 681
Early research (Phase 1)Active Not RecruitingNCT06564194
What this trial is testing

Evaluate JCXH-108, an mRNA-based Vaccine Against RSV

Who this might be right for
Respiratory Syncytial Virus (RSV)Infectious Disease
Immorna Biotherapeutics, Inc. 75
Not applicableStudy completedNCT01090557
What this trial is testing

Exhaled Nitric Oxide in Respiratory Syncytial Virus (RSV) Bronchiolitis: a Pilot Study

Who this might be right for
RSV InfectionBronchiolitis
Winthrop University Hospital 60
Not applicableActive Not RecruitingNCT05443607
What this trial is testing

Transplacental Transmission of RSV (TTRSV)

Who this might be right for
SARS CoV 2 InfectionRespiratory Syncytial Virus (RSV)Bronchiolitis+1 more
Tulane University 300
Early research (Phase 1)WithdrawnNCT02864628
What this trial is testing

RSV-MVA-BN Vaccine Phase I Trial, Intranasal Application in Adults.

Who this might be right for
Respiratory Syncytial Virus Infections
Bavarian Nordic
Not applicableUnknownNCT06392451
What this trial is testing

LIAISON NES Influenza (FLU) A/B, Respiratory Syncytial Virus (RSV), & Coronavirus Disease 2019 (COVID-19) in Symptomatic Patients in Australia

Who this might be right for
Influenza AInfluenza Type BCoronavirus Disease 2019+8 more
DiaSorin Molecular LLC 1,000
Testing effectiveness (Phase 2)Ended earlyNCT03656510
What this trial is testing

Study to Evaluate Safety and Antiviral Activity of Doses of JNJ-53718678 in Children (>=28 Days to <=3 Years) With Respiratory Syncytial Virus Infection

Who this might be right for
Respiratory Syncytial Virus Infections
Janssen Research & Development, LLC 246
Not applicableStudy completedNCT05506670
What this trial is testing

Disease Burden of RSV

Who this might be right for
RSV Acute Respiratory Infection
Hospices Civils de Lyon 84
Testing effectiveness (Phase 2)Study completedNCT04068792
What this trial is testing

A Two-Part Infant Study for Early Diagnosis of Respiratory Syncytial Virus (RSV) and Evaluation of JNJ-53718678 in RSV Acute Respiratory Tract Disease

Who this might be right for
Respiratory Syncytial Viruses
Janssen Research & Development, LLC 22
Early research (Phase 1)Study completedNCT04444284
What this trial is testing

Study of the Safety and Immunogenicity of an Intranasal Vaccine for Respiratory Syncytial Virus in Seropositive Children

Who this might be right for
Respiratory Syncytial Virus Infections
Meissa Vaccines, Inc. 34
Early research (Phase 1)Active Not RecruitingNCT06645665
What this trial is testing

Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above

Who this might be right for
Respiratory Syncytial Virus Infections
Shenzhen Shenxin Biotechnology Co., Ltd 240
Not applicableUnknownNCT05348616
What this trial is testing

Impact of the Covid-19 on RSV

Who this might be right for
RhinovirusRSV Infection
Hospices Civils de Lyon 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT06984094
What this trial is testing

Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults

Who this might be right for
RSV InfectionHuman Metapneumovirus InfectionParainfluenza Infection
Clover Biopharmaceuticals AUS Pty 612
Large-scale testing (Phase 3)Ended earlyNCT04980391
What this trial is testing

A Study on the Safety and Immune Response to an Unadjuvanted RSV Maternal Vaccine, in High Risk Pregnant Women Aged 15 to 49 Years and Infants Born to the Vaccinated Mothers

Who this might be right for
Respiratory Syncytial Virus Infections
GlaxoSmithKline 384
Next Page